Merlin, Inc. 8-K

What Happened

• Merlin, Inc. (MRLN) announced on April 29, 2026 that it entered into a securities purchase agreement for a private placement to sell 8,000,000 shares of common stock at $10.00 per share and warrants exercisable for an aggregate of 4,000,000 common shares, for approximately $80 million in gross proceeds. The company expects to close the Private Placement and issue the securities on May 1, 2026, subject to customary closing conditions.
• In connection with the Private Placement, the company amended and restated its registration rights agreement (the “Second A&R Registration Rights Agreement”), under which Merlin agreed to file a registration statement within 30 days (subject to exceptions) to register resale of the securities and to use commercially reasonable efforts to have it declared effective.

Key Details

• Amount: 8,000,000 common shares at $10.00/share; gross proceeds ≈ $80 million.
• Warrants: exercisable for an aggregate of 4,000,000 common shares (Underlying Shares).
• Timing: Purchase Agreement and 8-K filed April 29, 2026; expected closing and issuance on May 1, 2026.
• Corporate effects: Issuance is expected to trigger anti-dilution adjustments to the conversion price of the company’s 12.0% Series A Cumulative Convertible Preferred Stock and to exercise prices of certain existing warrants per their terms.
• Offering terms: Private placement exempt from registration under Section 4(a)(2); purchaser represented it is an accredited investor and securities were offered without general solicitation.

Why It Matters

• The financing provides material new capital (≈ $80M) that Merlin says it will use to advance platform development, fund regulatory approval work, scale program capacity, and support existing and new customer contracts — all items tied to growth and operations.
• For investors, the deal both reduces near-term funding risk and increases potential future share dilution: the issuance plus warrants could increase outstanding common shares, and anti-dilution adjustments will affect preferred conversion and certain warrant exercise prices. The amended registration rights agreement also sets a timeline for resale registration, which could affect future share liquidity.